Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Disorders of Leukocytes01:27

Disorders of Leukocytes

1.0K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.0K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

641
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
641
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

18
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
18
Classification of Leukocytes01:30

Classification of Leukocytes

2.2K
Leukocytes are classified into two groups based on the presence or absence of cytoplasmic granules. Granular leukocytes, which contain granules, belong to the myeloid lineage and are divided into three subtypes: neutrophils, eosinophils, and basophils. These cells are roughly spherical and characterized by the granules in their cytoplasm.
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
2.2K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

323
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
323

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An NP-led bowel management program for patients with spina bifida.

Journal of pediatric urology·2026
Same author

A practical guide to strength/resistance training in pediatrics ages 7 through 18 years old.

Current problems in pediatric and adolescent health care·2025
Same author

Keeping patients moving: Understanding appropriate adaptive devices for positioning and mobility.

Current problems in pediatric and adolescent health care·2025
Same author

Paroxysmal sympathetic hyperactivity in children: An updated narrative review.

Current problems in pediatric and adolescent health care·2025
Same author

Neurofibromatosis review with focus on rehabilitation intervention.

Current problems in pediatric and adolescent health care·2025
Same author

Effectiveness and safety of abobotulinumtoxinA in pediatric lower limb spasticity: A phase IV, prospective, observational, multicenter study.

Developmental medicine and child neurology·2025
Same journal

Understanding the role of environmental pollutants on preterm births in Puerto Rico: The PROTECT approach.

Current problems in pediatric and adolescent health care·2026
Same journal

Foreword: Vitamin D.

Current problems in pediatric and adolescent health care·2026
Same journal

Understanding the environmental determinants of preterm birth.

Current problems in pediatric and adolescent health care·2026
Same journal

Vitamin D and skeletal health: Practical approaches for bone health across the lifespan.

Current problems in pediatric and adolescent health care·2026
Same journal

High-dose Vitamin D and Non-Skeletal Health.

Current problems in pediatric and adolescent health care·2026
Same journal

Dermatology eConsult: Leveraging technology to reduce barriers to pediatric dermatology care at school-based health centers.

Current problems in pediatric and adolescent health care·2026
See all related articles

Related Experiment Video

Updated: Aug 12, 2025

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.0K

Introduction to leukodystrophy

Mi Ran Shin1, Kylie Mortgart2, Amy May3

  • 1Assistant Professor of Pediatrics, George Washington University, Children's National Hospital, Washington, DC, United States.

Current Problems in Pediatric and Adolescent Health Care
|January 25, 2023
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Mouse Models of Periventricular Leukomalacia
06:24

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

30.0K
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.2K

Related Experiment Videos

Last Updated: Aug 12, 2025

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.0K
Mouse Models of Periventricular Leukomalacia
06:24

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

30.0K
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.2K